Aerpace promoter trust infuses ₹48.82 cr via warrants, PNB adds ₹70 cr line
Pre-revenue nano-cap gets 11%+ capital infusion from NK Family Private Trust and a ₹70 crore facility from Punjab National Bank, alongside seasoned advisor appointments.
— 1 earlier story on Aerpace Industries Ltd. →What's new
- Board approved 1.5 crore convertible warrants at ₹32.55 each to promoter trust NK Family Private Trust, raising ₹48.82 cr.
- Credit facility of ₹70 crore secured from Punjab National Bank for working capital.
- Former SBI chairman Rajnish Kumar appointed as board advisor; Ms. Anshu Shukla Pandey joins as independent director.
Why this matters
For a company with zero revenue and a ₹9 crore quarterly loss, a ₹48.82 crore promoter-led infusion plus a ₹70 crore bank line is a vote of confidence that changes the balance sheet. The warrants require 25% upfront, so cash is coming in now. Rajnish Kumar's presence adds governance weight to a nano-cap that needs it.
What we're watching
- Conversion timeline: warrants can be exercised within 18 months, diluting equity at ₹32.55.
- How the ₹70 crore PNB facility is deployed; working capital needs for a pre-revenue firm.
- Whether the company gives revenue guidance in the next quarterly update.
The full read
Aerpace Industries has zero revenue and a ₹9 crore quarterly loss, yet its board just approved a ₹48.82 crore warrant issue to promoter trust NK Family Private Trust and secured a ₹70 crore credit line from PNB. The warrants ( 1.5 crore at ₹32.55 each) represent an 11%+ capital infusion relative to market cap. They are convertible within 18 months and require 25% upfront, which brings immediate cash. The parallel PNB facility nearly doubles the available liquidity. The appointments of former SBI chairman Rajnish Kumar as advisor and a new independent director add governance heft. For a nano-cap with no top line, structured capital from promoters and a bank is rare. The test now is whether Aerpace can deploy this into revenue.
Questions answered
- How much capital is Aerpace raising from the preferential issue?
- ₹48.82 crore via 1.5 crore convertible warrants at ₹32.55 each, issued to promoter group entity NK Family Private Trust.
- What are the terms of the warrants?
- Each warrant has a face value of Re 1 and a premium of ₹31.55, is convertible into one equity share within 18 months, and requires 25% upfront payment.
- Why is a ₹70 crore credit facility significant for Aerpace?
- With zero revenue and a ₹9 crore quarterly loss, the ₹70 crore facility from PNB provides substantial working capital, nearly 14% of market cap, and signals bank confidence.
- Who are the new board members and advisors?
- Ms. Anshu Shukla Pandey was appointed independent director. Former SBI chairman Rajnish Kumar and Mr. Nikunj Kampani were appointed board advisors.
- What does this fundraise imply for existing shareholders?
- The ₹48.82 crore infusion is 11%+ of market cap and comes from promoters, reducing dilution risk from external investors. However, warrant conversion will add shares over time.
Aerpace Industries Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on AERPACE →- 9 Jul 2026 · 6:19 PM IST Aerpace promoter trust infuses ₹48.82 cr via warrants, PNB adds ₹70 cr line
- 3d ago Aerpace board to weigh preferential issue, no details yet